Related Experiment Videos
Management of Essential Hypertension
Keith C Ferdinand1, Samar A Nasser2
1Tulane Heart and Vascular Institute, Tulane University School of Medicine, 1430 Tulane Avenue, #8548, New Orleans, LA 70112, USA.
Insights
Essential hypertension management is crucial for reducing cardiovascular risks. African Americans face higher prevalence and less control, necessitating effective pharmacotherapy with diuretics, calcium channel blockers, or ARBs/ACE inhibitors.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Essential hypertension significantly contributes to cardiovascular morbidity and mortality.
- Hypertension prevalence and control vary across racial/ethnic groups in the US, with African Americans experiencing the highest prevalence and least control.
- While lifestyle modifications are foundational, most patients require pharmacotherapy, often combination therapy.
Purpose of the Study:
- To summarize current recommendations for the pharmacologic treatment of essential hypertension.
- To highlight disparities in hypertension prevalence and control among different racial/ethnic groups.
- To outline the principal drug classes recommended for initial hypertension management.
Main Methods:
- Review of current clinical guidelines and literature on essential hypertension treatment.
- Analysis of epidemiological data regarding hypertension prevalence and control by race/ethnicity.
- Synthesis of evidence supporting first-line pharmacologic interventions.
Main Results:
- Essential hypertension treatment is vital for cardiovascular risk reduction.
- Significant racial/ethnic disparities exist in hypertension prevalence and control within the US.
- Thiazide-type diuretics, calcium channel blockers, and ACE inhibitors/ARBs are recommended as initial pharmacotherapy.
Conclusions:
- Effective management of essential hypertension is critical for public health.
- Addressing racial/ethnic disparities in hypertension control is a priority.
- Specific drug classes form the cornerstone of initial pharmacotherapy for essential hypertension.
Abstract:
The treatment of essential hypertension is one of the most critical interventions to decrease cardiovascular morbidity and mortality. The prevalence of hypertension in the US varies across race/ethnicity with African Americans having the highest prevalence and overall less control among racial/ethnic minorities compared with non-Hispanic whites. Therapeutic lifestyle modifications are the bedrock of essential hypertension control, but most patients with hypertension will require pharmacotherapy, usually with multiple medications often in combination. Overall, the principal drug classes recommended as initial pharmacotherapy are thiazide-type diuretics, calcium channel blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.